Skip to content
2000
Volume 16, Issue 8
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Background: In an effort to establish new drug candidates with improved antiproliferative activity, we report here a novel class of compounds designed rationally by the replacement of an ethyl group in tamoxifen with a methylene (1H-1,2,4-triazole) and the introduction of 1,4- substituted 1,2,3-triazoles in the basic side chain. Methods: Magnetically separable iron oxide nanoparticles have been found to effectively catalyze the one-pot multicomponent click synthesis of 1,4-disubstituted 1,2,3-triazole conjugates in water. IR, 1HNMR, 13CNMR and HRMS experiments have been implemented for the unmistakable determination of the regiochemistry of the process. The novel compounds were evaluated for their antiproliferative activity against four human tumor cell lines, namely, MCF-7, MDA-MB-231, HeLa, and A549. Cell growth inhibition was assessed according to the standard Sulforhodamine B (SRB) cell proliferation method. Results: The most active compounds 4h, 4n and 5a have been identified with superior GI50 values in the range of 0.13–0.31 μM as compared with the reference drug, tamoxifen (0.25-0.72 μM). Conclusion: Additionally, taking the stereochemistry into consideration, E isomers seem slightly more active towards the tested cancer cell lines with respect to Z isomers.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180815666180621100314
2019-08-01
2025-04-23
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180815666180621100314
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test